Official UK procurement notice
Supply of Transfer bags - Reagent Production
Authority: NHS Blood and Transplant (Central government)
What is being bought
Published requirement descriptionTransfer bags ranging from 400ml to 10 litres are used during the manufacture of NHSBT Reagent products, for In Vitro Diagnostic use only.
CPV: Medical consumables
The lotProcurement structure
single lot · no lot value publishedLot #1Reagents is part of the Red Cell Immunohaematology (RCI) function within the Clinical…Planned
Reagents is part of the Red Cell Immunohaematology (RCI) function within the Clinical Directorate of National Health Service Blood and Transplant (NHSBT). Reagents is located in Liverpool and produces a range of in vitro diagnostic products including those manufactured from red cell donations. <br/><br/>Transfer bags ranging from 400ml to 10 litres are used during the manufacture of NHSBT Reagent products, for In Vitro Diagnostic use only.<br/><br/>The purpose of the transfer bag is for storage, for up to 8 weeks of the following products:<br/>
- Red cell suspensions <br/>
- Plasma/serum products<br/>
- Solutions containing proteolytic enzymes <br/><br/>The Reagents are then dispensed from these transfer bags into their final product containers, which are used for in vitro diagnostic testing.<br/>We are looking to appoint a supplier for the ongoing Supply of these transfer bags. Suppliers do not have to tender for all bags sizes and can specify this as part of the tender response<br/><br/>It is NHSBTs’ intention to engage with the market to gather detailed information about the market capabilities. The format for this will be communicated to those that respond to this PIN. Virtual Supplier Engagement days are likely to be a supplier presentation followed by Q&A session by 11 and 14 August, 2023. Expressions of interest should be e-mailed to Coco.Otiotio@nhsbt.nhs.uk by no later than 17.00hrs (GMT) on 21/07/2023 and this should include a list of your potential attendees.<br/><br/>No business whatsoever is guaranteed under any resulting framework agreement or contract, and there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position.
Procedure terms & legal framework
From the official record- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Past planning notice
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 7 Jul 2023, 15:35 BST
- Last source update
- 7 Jul 2023, 15:35 BST
- FTS notice number
2023/S 000-019500- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03dfe8Find a Tender
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- —
Timeline
7 Jul 2023 → 1 Nov 2023 · 2 dates- Notice published7 Jul 2023, 15:35 BST
- Tender notice expected1 Nov 2023
Commercial outcome & contract awards
Pipeline notice- Awards (0)
- No award published
- Contracts (0)
- No contract published
- Bid statistics
- No aggregate bid statistics published
Contracting authority & participating public bodies
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.